Maquoi, E., Sounni, N. E., Devy, L., Olivier, F., Frankenne, F., Krell, H.-W., Grams, F., Foidart, J.-M. and Noël, A. (2004) Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor. Clinical Cancer Research, 10, 4038-4047.
https://doi.org/10.1158/1078-0432.CCR-04-0125

has been cited by the following article:

• TITLE: Synthesis and Antibacterial Activities of New 2-(Benzylthio)pyrimidines and 2-(Benzimidazolylmethylthio)pyrimidines Derivatives

  AUTHORS: Achi Patrick-Armand, Coulibali Siomenan, Zon Doumade, Timotou Adéyolé, Bolou Eric, Touré Daouda, Sissouma Drissa, Adjou Ané

  KEYWORDS: 2-Thiopyrimidine, Benzylthiouracil, Benzimidazole, Antibacterial Activity

  JOURNAL NAME: Open Journal of Medicinal Chemistry, Vol.11 No.3, September 18, 2021

  ABSTRACT: A series of 2-(benzylthio)pyrimidines (6a-l) and 2-(benzimidazolylmethylthio)-pyrimidines derivatives (6m and 6n) analogues of ethyl 2-(benzylthio)-6-methyl-4-phenyl-1,4-dihydropyrimidine-5-carboxylates and ethyl 2-(((1H-benzimidazol-2-yl)methyl)thio)-6-methyl-4-phenyl-1,4-dihydropyri-midine-5-carboxylates were prepared and evaluated for antibacterial activity. These compounds were obtained by condensation of 2-thiopyrimidines (4) with benzyl halides or 2-(chloromethyl)-1H-benzimidazole (5) in the presence of a base. All compounds were characterized by 1H, 13C and HRMS spectra. Out of fourteen, only eight compounds were screened against multi-resistant strains of Escherichia coli and Staphylococcus aureus. The results revealed that all of them were found to possess significant antibacterial activity against the germs tested. Compounds 6c, 6d, 6h and 6m were more active on S. aureus and compounds 6h and 6m more active on E. coli.